Biofrontera Inc.

NASDAQ: BFRI · Real-Time Price · USD
0.70
0.01 (0.73%)
At close: May 12, 2025, 10:03 AM

Biofrontera Revenue Breakdown

Period Ending Dec 31, 2023 Dec 31, 2022
Government and Payor Rebates Revenue 310K 675K
Government and Payor Rebates Revenue Growth -54.07% n/a
Prompt Pay Discounts Revenue 6K 264K
Prompt Pay Discounts Revenue Growth -97.73% n/a
Returns Revenue 52K 67K
Returns Revenue Growth -22.39% n/a
Co-pay Assistance Program Revenue 165K 53K
Co-pay Assistance Program Revenue Growth +211.32% n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 8.17M 8.43M 7.95M 9.25M 8.77M 8.62M 11.55M 9.83M 10.21M 7.94M 10.02M 7.71M 9.28M 17.25M 5.75M 4.92M 4.16M 4.3M 3.67M 5.98M
Selling, General, and Administrative Revenue Growth -3.01% +6.01% -14.09% +5.53% +1.69% -25.36% +17.51% -3.73% +28.63% -20.76% +29.88% -16.88% -46.22% +200.10% +16.78% +18.23% -3.23% +17.25% -38.68% n/a
Research and Development Revenue 782K 669K 621K 17K 33K 33K 11K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth +16.89% +7.73% +3552.94% -48.48% 0.00% +200.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a